Brief: NovaBay Reports Q3 Loss Per Share Of $0.08

Stablecoin Development

12/11/2020 21:19

Nov 12 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.08
    * NET PRODUCT REVENUE FOR Q3 OF 2020 WAS $2.2 MILLION, A 34%
INCREASE FROM $1.6 MILLION FOR Q3 OF 2019
    * REPORTED CASH AND CASH EQUIVALENTS OF $13.4 MILLION AS OF
SEPTEMBER 30, 2020

Source text for Eikon:  ID:nBw5MfLZRa 
Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;))